Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Malignant neoplasms that either originate from the bone marrow (e.g. myeloid leukemias) or involve the bone marrow as secondary-metastatic tumors (e.g. metastatic carcinomas to the bone marrow). --2003
Biomarker and diagnostic research for bone marrow cancer has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy and biologic therapy. Research is primarily sponsored by academic and government institutions.
225 publications have been identified in PubMed for bone marrow cancer. Kisho has analyzed 99 by research type. Research spans Basic Science / Preclinical (46%), Review / Meta-Analysis (27%), and Clinical Trial Publication (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 46 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:54 PM UTC
Research summaries | 27 | 27% |
Clinical study results | 7 | 7% |
New treatment approaches | 7 | 7% |
Testing and diagnosis research | 5 | 5% |
Disease patterns and progression | 3 | 3% |
Other research | 2 | 2% |
Patient case studies | 2 | 2% |
Nasr MM (2026). [PMID: 41105683](https://pubmed.ncbi.nlm.nih.gov/41105683/). *Cancer Res*. [Basic Science / Preclinical]
Kruschewsky WLL (2026). [PMID: 42047162](https://pubmed.ncbi.nlm.nih.gov/42047162/). *Mycoses*. [Review / Meta-Analysis]
Wang S (2026). [PMID: 41619722](https://pubmed.ncbi.nlm.nih.gov/41619722/). *Cell Rep Med*. [Basic Science / Preclinical]
Li L (2026). [PMID: 41592325](https://pubmed.ncbi.nlm.nih.gov/41592325/). *Blood*. [Diagnostic / Biomarker]
Giannini M (2026). [PMID: 41484482](https://pubmed.ncbi.nlm.nih.gov/41484482/). *Commun Biol*. [Basic Science / Preclinical]
Shu P (2026). [PMID: 41605906](https://pubmed.ncbi.nlm.nih.gov/41605906/). *Signal Transduct Target Ther*. [Gene Therapy / Novel Therapeutics]
Wang J (2026). [PMID: 41481427](https://pubmed.ncbi.nlm.nih.gov/41481427/). *Gut Microbes*. [Basic Science / Preclinical]
Ravalet N (2025). [PMID: 40712856](https://pubmed.ncbi.nlm.nih.gov/40712856/). *Clin Immunol*. [Basic Science / Preclinical]
Jurczyszyn A (2025). [PMID: 40231696](https://pubmed.ncbi.nlm.nih.gov/40231696/). *Pol Arch Intern Med*. [Review / Meta-Analysis]
Crawford CK (2025). [PMID: 40129798](https://pubmed.ncbi.nlm.nih.gov/40129798/). *Radiol Case Rep*. [Case Report / Case Series]